Boston Scientific acquires Apollo Endosurgery

并购
Boston Scientific has announced the close of its acquisition of Apollo Endosurgery, a medical technology company primarily focused on the design, development and commercialisation of less invasive medical devices to advance gastrointestinal therapeutic endoscopy and endobariatrics. “The close of this acquisition is an exciting step forward in our ability to provide our customers and their patients with a more comprehensive suite of endoluminal surgery (ELS) and endobariatric solutions,” said Mike Jones, senior vice president and president, Endoscopy, Boston Scientific. “We look forward to welcoming new talent to our Endoscopy team that will help advance innovation for physicians to improve patient care.” The addition of Apollo Endosurgery devices will expand upon the current Boston Scientific ELS portfolio and capabilities, particularly in the areas of closure and suturing, while enabling a measured entry into the endobariatric market.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。